MCID: FLL028
MIFTS: 21

Fallopian Tube Carcinosarcoma

Categories: Cancer diseases, Reproductive diseases

Aliases & Classifications for Fallopian Tube Carcinosarcoma

MalaCards integrated aliases for Fallopian Tube Carcinosarcoma:

Name: Fallopian Tube Carcinosarcoma 12 14 69
Fallopian Tube Malignant Mixed Mesodermal Tumor 12
Fallopian Tube Malignant Mixed Mullerian Tumor 12

Classifications:



External Ids:

Disease Ontology 12 DOID:1970
NCIt 46 C40124
UMLS 69 C1517117

Summaries for Fallopian Tube Carcinosarcoma

Disease Ontology : 12 A fallopian tube cancer that is characterized as a mixture of carcinoma and sarcoma and has material basis in epithelial tissue and has material basis in connective tissue.

MalaCards based summary : Fallopian Tube Carcinosarcoma, also known as fallopian tube malignant mixed mesodermal tumor, is related to venous hemangioma and adenomatoid tumor. An important gene associated with Fallopian Tube Carcinosarcoma is WT1 (Wilms Tumor 1), and among its related pathways/superpathways is Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Bevacizumab and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include endothelial.

Related Diseases for Fallopian Tube Carcinosarcoma

Graphical network of the top 20 diseases related to Fallopian Tube Carcinosarcoma:



Diseases related to Fallopian Tube Carcinosarcoma

Symptoms & Phenotypes for Fallopian Tube Carcinosarcoma

Drugs & Therapeutics for Fallopian Tube Carcinosarcoma

Drugs for Fallopian Tube Carcinosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 16)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bevacizumab Approved, Investigational Phase 1 216974-75-3
2
Carboplatin Approved Phase 1 41575-94-4 10339178 38904 498142
3
Cisplatin Approved Phase 1 15663-27-1 2767 441203 84093
4
Paclitaxel Approved, Vet_approved Phase 1 33069-62-4 36314
5
Veliparib Investigational Phase 1 912444-00-9 11960529
6 Albumin-Bound Paclitaxel Phase 1
7 Angiogenesis Inhibitors Phase 1
8 Angiogenesis Modulating Agents Phase 1
9 Antibodies Phase 1
10 Antibodies, Monoclonal Phase 1
11 Antimitotic Agents Phase 1
12 Antineoplastic Agents, Phytogenic Phase 1
13 Endothelial Growth Factors Phase 1
14 Immunoglobulins Phase 1
15 Mitogens Phase 1
16 Poly(ADP-ribose) Polymerase Inhibitors Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Active, not recruiting NCT00989651 Phase 1 Carboplatin;Cisplatin;Paclitaxel;Veliparib

Search NIH Clinical Center for Fallopian Tube Carcinosarcoma

Genetic Tests for Fallopian Tube Carcinosarcoma

Anatomical Context for Fallopian Tube Carcinosarcoma

MalaCards organs/tissues related to Fallopian Tube Carcinosarcoma:

38
Endothelial

Publications for Fallopian Tube Carcinosarcoma

Variations for Fallopian Tube Carcinosarcoma

Expression for Fallopian Tube Carcinosarcoma

Search GEO for disease gene expression data for Fallopian Tube Carcinosarcoma.

Pathways for Fallopian Tube Carcinosarcoma

Pathways related to Fallopian Tube Carcinosarcoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.75 NCAM1 WT1

GO Terms for Fallopian Tube Carcinosarcoma

Sources for Fallopian Tube Carcinosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....